Posters | April 16, 2014

Challenges In Biosimilar Monoclonal Antibody Cell Culture Process Development — Media Optimization Is A Key To Success

Request Information

Biosimilar, a term synonymous to "follow-on biologic" requires very stringent and high standards of comparability with the original biologic drug that is being replicated.  Unlike conventional small molecules and chemical generics, "biogenerics" or biosimilars, especially monoclonal antibodies, have complex structure and function that are affected by slight changes in the manufacturing process.  Additionally, the rigor and stringent control standards imposed for biosimilars further increase the challenge and complexity for manufacturing process development of biosimilars.

For full access to this content, please Register or Sign In.

Access Content Challenges In Biosimilar Monoclonal Antibody Cell Culture Process Development — Media Optimization Is A Key To Success
Newsletter Signup
Newsletter Signup